Skip to main content
Fig. 1 | BMC Veterinary Research

Fig. 1

From: Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells

Fig. 1

Effects of single agent erlotinib on clonogenic survival. Canine OSA cells treated with erlotinib at 10 μM for 4-6 h (“erlotinib”). Experiments were repeated three times and average of results are shown. Erlotinib showed single agent activity through reduction in clonogenic survival in 2 out of 3 cell lines. * p < 0.05 indicates statistical significant reduction in clonogenic survival compared to control

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us